通讯作者: 王湘, wangxiang5123@126.com; 邵亚娟, ShaoYJ@pumch.cn

DOI：10.12201/bmr.202408.00018

74例成人炎性肌成纤维细胞瘤的临床病理分析与治疗

• 摘要：炎性肌纤维母细胞瘤(IMT)是一种罕见的间充质肿瘤，多发于软组织和内脏器官，成人IMT的临床和病理特点尚不清楚。 这项研究强调了诊断IMT时综合使用组织病理学、免疫组织化学和基因检测的重要性。此外，ALK阳性的患者应考虑使用ALK抑制剂，尤其是在有较高ALK阳性率的肺IMT患者中。IMT存在长期复发风险，定期随访是必要的。 方法: 收集2010-2023年在北京协和医院诊断为IMT的74例患者信息，分析临床病理资料、治疗情况及随访结果。 结果: 74例患者中女性34例，男性40例，平均年龄为50岁，多数患者无临床症状。最常见的部位是头颈部(24.1%)，其次是肺部(21.6%)。31%的患者有ALK阳性，其中肺IMT的阳性率最高(45.5%)。大多数患者接受手术切除，一些患者接受了包括放疗、化疗或ALK抑制剂的术后治疗。整体1年、3年、5年、10年OS率分别为78.4%、70.9%、69.2%、69.2%。 局限性:本研究是一项单中心回顾性研究，患者特征的代表性有限。药物治疗患者的样本量相对较小且具有异质性，使得进一步的系统分析变得困难。 结论: IMT具有明显的临床异质性，其中肺IMT的ALK阳性率最高。手术切除仍然是主要的治疗方式，但IMT存在长期复发风险，更有效的治疗是必要的，ALK阳性患者应考虑ALK抑制剂如克唑替尼等。此外，对IMTs的分子特征的进一步研究有助于提高诊断准确性，并有利于改进治疗方案。

  关键词： 炎性肌纤维母细胞瘤; 临床病理学; ALK; 预后

   

  Abstract: Objective: Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm with diverse behaviors occurring in soft tissues and visceral organs. The clinical and pathological features of IMT in adult patients are not well understood. This study highlights the importance of comprehensive diagnostics, including histopathology, immunohistochemistry, and genetic testing, in managing IMTs. High ALK positivity in lung IMTs suggests targeted therapies' benefit. ALK inhibitors should be considered for ALK-positive tumors. Regular follow-up is crucial due to relapse risk. Methods: We conducted a retrospective analysis of 74 patients diagnosed with IMTs at Peking Union Medical College Hospital between 2010 and 2023. Clinicopathological data, treatments, and outcomes were collected and analyzed. Results: Among the 74 patients (34 females, 40 males) at an average age of 50, the majority were asymptomatic. The most common tumor locations were the head and neck (24.1%), followed by lung (21.6%). Anaplastic lymphoma kinase (ALK) positivity was identified in 31% of cases, with the highest prevalence in lung IMTs (45.5%). Most patients underwent surgical resection, and some received postoperative treatments including radiotherapy, chemotherapy, or ALK inhibitors. The 1-year, 3-year, 5-year, and 10-year OS rates were 78.4%, 70.9%, 69.2%, and 69.2%，respectively. Limitations: This is a single-center retrospective study, and the characteristics of these patients may not be representative of all adult IMT patients. While the sample size of drug-treated patients is relatively small and heterogeneous, making further systematic analysis difficult. The mechanism of resistance to ALK inhibitors has not been determined. Conclusions: IMTs exhibit significant clinical heterogeneity, with lung IMTs demonstrated the highest rate of ALK positivity. While surgical resection remains the primary treatment modality, the observed rates of relapse and mortality underscore the necessity for more effective therapeutic strategies. ALK inhibitor such as crizotinib should be consideration for ALK positive patients. A deeper understanding of the molecular characteristics of IMTs may help to enhance diagnostic accuracy and inform the development of improved treatment options.

  Key words: Inflammatory myofibroblastic tumors; Clinicalpathological; Anaplastic lymphoma kinase; prognosis

  提交时间：2024-08-15

  版权声明：作者本人独立拥有该论文的版权，预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。
• html

• 图表

• 何景梅, 张晓玲, 陈琨. 系统性炎症反应指数、乳酸脱氢酶及谷草转氨酶用于识别成人暴发性心肌炎高危人群的价值分析. 2024. doi: 10.12201/bmr.202410.00070

  段嘉敏, 蔡旭东. 基于“亢害承制”理论探讨巨噬细胞极化在慢性肾脏病肾纤维化发展中的作用. 2024. doi: 10.12201/bmr.202407.00027

  吴苏龙, 曾文美, 郑玥, 黎毅敏. 人中性粒细胞多肽对急性呼吸窘迫综合征患者病情及预后评估作用. 2024. doi: 10.12201/bmr.202410.00060

  叶贝, 刘顺林. CPNE1、ZWILCH在肺腺癌演进中的表达及与预后的相关性分析. 2024. doi: 10.12201/bmr.202406.00030

  邹倩, 陈美华, 张志迪. 中青年淋巴瘤患者二元应对的影响因素研究. 2024. doi: 10.12201/bmr.202410.00013

  邹宝华, 丛明华. Prevalence of symptoms of cancer patients and Feasibility of Patient Diary Tool (PDT): a prospective, multi-center, pilot study. 2024. doi: 10.12201/bmr.202404.00040

  冀鹏磊, 髙崴崴, 李佳霖, 刘待见, 王昱林. 免疫炎症相关指数与重症肺炎转归相关性分析. 2024. doi: 10.12201/bmr.202409.00062

  刘红萍, 杨杰, 庞国明, 邢颖, 李鹏辉, 吴敏, 温宵宵, 李洪皎, 文天才. 基于改进关联规则与Logistic回归算法集成的2型糖尿病中医证型鉴别研究. 2024. doi: 10.12201/bmr.202404.00034

  周林. 血清GP73联合预后营养指数对HCC患者TACE术后预后的评估价值. 2024. doi: 10.12201/bmr.202409.00043

  张彤阳, 孙原, 李弘, 陈忠悦, 王迪, 刘江永. 自身免疫性胶质纤维酸性蛋白星形细胞病1例. 2024. doi: 10.12201/bmr.202408.00068

• 序号	提交日期	编号	操作
  1	2024-08-09	bmr.202408.00018V1	下载

• 公开评论  匿名评论  仅发给作者 提交评论